This assay is used to monitor exposure to arsenic, wellness, and therapy during treatment of chronic myelocytic leukemia.
This Arsenic blood test is tested to detect recent arsenic exposure. Arsenic can be identified in the blood approximately 1 day after exposure to around 3 weeks after. It can also be used to monitor the effectiveness of treatment.